Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 56

1.

Efficacy and safety of inhaler steroids in COPD patients: Systematic review and meta-analysis of randomized placebo-controlled trials.

Karbasi-Afshar R, Aslani J, Ghanei M.

Caspian J Intern Med. 2014 Summer;5(3):130-6. Review.

PMID:
25202439
[PubMed]
Free PMC Article
2.

Comparative efficacy of inhaled corticosteroid and long-acting beta agonist combinations in preventing COPD exacerbations: a Bayesian network meta-analysis.

Oba Y, Lone NA.

Int J Chron Obstruct Pulmon Dis. 2014 May 12;9:469-79. doi: 10.2147/COPD.S48492. eCollection 2014. Review.

PMID:
24872685
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The Saudi Guidelines for the Diagnosis and Management of COPD.

Khan JH, Lababidi HM, Al-Moamary MS, Zeitouni MO, Al-Jahdali HH, Al-Amoudi OS, Wali SO, Idrees MM, Al-Shimemri AA, Al Ghobain MO, Alorainy HS, Al-Hajjaj MS.

Ann Thorac Med. 2014 Apr;9(2):55-76. doi: 10.4103/1817-1737.128843.

PMID:
24791168
[PubMed]
Free PMC Article
4.

Real-life use of fluticasone propionate/salmeterol in patients with chronic obstructive pulmonary disease: a French observational study.

Roche N, Pribil C, Van Ganse E, Serrier P, Housset B, Poirier D, Texier N, Schück S, Boucot I.

BMC Pulm Med. 2014 Apr 2;14:56. doi: 10.1186/1471-2466-14-56.

PMID:
24694050
[PubMed - in process]
Free PMC Article
5.

Extrafine Beclomethasone/formoterol compared to Fluticasone/salmeterol Combination Therapy in COPD.

Singh D, Nicolini G, Bindi E, Corradi M, Guastalla D, Kampschulte J, Pierzchała W, Sayiner A, Szilasi M, Terzano C, Vestbo J; FUTURE (Foster Upgrades TherapeUtic care in REspiratory disease) study group.

BMC Pulm Med. 2014 Mar 12;14:43. doi: 10.1186/1471-2466-14-43.

PMID:
24621109
[PubMed - in process]
Free PMC Article
6.

Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?

Theron AJ, Steel HC, Tintinger GR, Feldman C, Anderson R.

Drug Des Devel Ther. 2013 Nov 22;7:1387-98. doi: 10.2147/DDDT.S50995. eCollection 2013. Review.

PMID:
24285920
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Comparative efficacy of long-acting bronchodilators for COPD: a network meta-analysis.

Cope S, Donohue JF, Jansen JP, Kraemer M, Capkun-Niggli G, Baldwin M, Buckley F, Ellis A, Jones P.

Respir Res. 2013 Oct 7;14:100. doi: 10.1186/1465-9921-14-100.

PMID:
24093477
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Optimizing safety of COPD treatments: role of the nurse practitioner.

Spencer P, Hanania NA.

J Multidiscip Healthc. 2013;6:53-63. doi: 10.2147/JMDH.S35711. Epub 2013 Feb 21.

PMID:
23459224
[PubMed]
Free PMC Article
9.

Chronic obstructive pulmonary disease lost in translation: Why are the inhaled corticosteroids skeptics refusing to go?

Ai-Kassimi FA, Alhamad EH.

Ann Thorac Med. 2013 Jan;8(1):8-13. doi: 10.4103/1817-1737.105711.

PMID:
23441006
[PubMed]
Free PMC Article
10.

The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease.

Decramer ML, Hanania NA, Lötvall JO, Yawn BP.

Int J Chron Obstruct Pulmon Dis. 2013;8:53-64. doi: 10.2147/COPD.S39018. Epub 2013 Jan 25. Review.

PMID:
23378756
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Abrupt withdrawal of inhaled corticosteroids does not result in spirometric deterioration in chronic obstructive pulmonary disease: Effect of phenotyping?

Al-Kassimi FA, Alhamad EH, Al-Hajjaj MS, Abba AA, Raddaoui E, Shaikh SA.

Ann Thorac Med. 2012 Oct;7(4):238-42. doi: 10.4103/1817-1737.102185.

PMID:
23189102
[PubMed]
Free PMC Article
12.

Comparison of the effect of high-dose inhaled budesonide and fluticasone on adrenal function in patients with severe chronic obstructive pulmonary disease.

Fahim A, Faruqi S, Wright CE, Kastelik JA, Morice AH.

Ann Thorac Med. 2012 Jul;7(3):140-4. doi: 10.4103/1817-1737.98846.

PMID:
22924071
[PubMed]
Free PMC Article
13.

Efficacy of indacaterol 75 μg versus fixed-dose combinations of formoterol-budesonide or salmeterol-fluticasone for COPD: a network meta-analysis.

Cope S, Kraemer M, Zhang J, Capkun-Niggli G, Jansen JP.

Int J Chron Obstruct Pulmon Dis. 2012;7:415-20. doi: 10.2147/COPD.S31526. Epub 2012 Jul 5.

PMID:
22848154
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Efficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: a study level and a patient level network meta-analysis.

Cope S, Zhang J, Williams J, Jansen JP.

BMC Pulm Med. 2012 Jun 25;12:29. doi: 10.1186/1471-2466-12-29.

PMID:
22732017
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Teaching the use of respiratory inhalers to hospitalized patients with asthma or COPD: a randomized trial.

Press VG, Arora VM, Shah LM, Lewis SL, Charbeneau J, Naureckas ET, Krishnan JA.

J Gen Intern Med. 2012 Oct;27(10):1317-25. Epub 2012 May 17.

PMID:
22592354
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Observational study on the impact of initiating tiotropium alone versus tiotropium with fluticasone propionate/salmeterol combination therapy on outcomes and costs in chronic obstructive pulmonary disease.

Chatterjee A, Shah M, D'Souza AO, Bechtel B, Crater G, Dalal AA.

Respir Res. 2012 Feb 17;13:15. doi: 10.1186/1465-9921-13-15.

PMID:
22340019
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials.

Tashkin DP, Doherty DE, Kerwin E, Matiz-Bueno CE, Knorr B, Shekar T, Gates D, Staudinger H.

Int J Chron Obstruct Pulmon Dis. 2012;7:73-86. doi: 10.2147/COPD.S29444. Epub 2012 Feb 3.

PMID:
22334770
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD.

Doherty DE, Tashkin DP, Kerwin E, Knorr BA, Shekar T, Banerjee S, Staudinger H.

Int J Chron Obstruct Pulmon Dis. 2012;7:57-71. doi: 10.2147/COPD.S27320. Epub 2012 Feb 3.

PMID:
22334769
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial.

Tashkin DP, Doherty DE, Kerwin E, Matiz-Bueno CE, Knorr B, Shekar T, Banerjee S, Staudinger H.

Int J Chron Obstruct Pulmon Dis. 2012;7:43-55. doi: 10.2147/COPD.S27319. Epub 2012 Feb 3. Erratum in: Int J Chron Obstruct Pulmon Dis. 2012;7:765.

PMID:
22334768
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Improvement of Airflow Limitation by Fluticasone Propionate/Salmeterol in Chronic Obstructive Pulmonary Disease: What is the Specific Marker?

Akamatsu K, Matsunaga K, Sugiura H, Koarai A, Hirano T, Minakata Y, Ichinose M.

Front Pharmacol. 2011 Jul 18;2:36. doi: 10.3389/fphar.2011.00036. eCollection 2011.

PMID:
21811461
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk